Pulmonary Embolism in Oncologic Patients

Interest in diagnosis and treatment of pulmonary embolism (PE), a potentially fatal disease, is always high, especially among oncologic patients. In fact, not only tumors but also chemotherapy increases the risk to develop thromboembolic events in these particular patients. Moreover, nowadays, it frequently happens to detect incidental PE by imaging examinations performed for other purposes and, as oncologic patients are surely the ones who undergo the most of the diagnostic procedures, they are also the ones that more often are found to be affected by incidental, asymptomatic, pulmonary embolism.


Silvia Tresoldi, Nicola Flor and Andrea Luciani

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • 3rd World Heart Congress
    April 19-20, 2018 Amsterdam, Netherlands
  • 24th Annual Cardiologists Conference
    June 11-13, 2018 Barcelona, Spain
Flyer image

Abstracted/Indexed in

  • Google Scholar
  • Geneva Foundation for Medical Education and Research